Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS]

Clinical trial NCT01134627 · TERMINATED

Trial details

NCT number: NCT01134627
Sponsor: Merck KGaA, Darmstadt, Germany
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2006-02-01
Primary completion: 2011-04-01
Enrollment: 305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.